FDA Inspection 1266886 — Imaging Endpoints II, LLC
The FDA completed an inspection of Imaging Endpoints II, LLC on April 4, 2025 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scottsdale, AZ (United States)
Additional Details
Sponsor, Contract Research Organization